Mangoceuticals, Inc. (MGRX) Operating income 2022–2025
Mangoceuticals, Inc. (MGRX) annual operating income history from SEC filings — each fiscal year as reported.
-$18.0MFY2025 · since FY2022: -$2.0M → -$18.0M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$18.0M | -126.2% |
| FY2024 | -$8.0M | +13.5% |
| FY2023 | -$9.2M | -362.9% |
| FY2022 | -$2.0M | — |
Source: SEC XBRL filings · For reference only · Not investment advice
More MGRX financial trends
MGRX RevenueMGRX Net incomeMGRX Net marginMGRX Gross profitMGRX Gross marginMGRX Operating marginMGRX Operating cash flowMGRX Free cash flowMGRX Capital expendituresMGRX Return on equityMGRX Stock buybacksMGRX Dividends paidMGRX Total assetsMGRX Total liabilitiesMGRX Shareholders’ equityMGRX overview →